Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160 USD | -0.83% | -1.71% | +29.01% |
Financials (USD)
Sales 2024 * | 266M | Sales 2025 * | 428M | Capitalization | 4.57B |
---|---|---|---|---|---|
Net income 2024 * | 62M | Net income 2025 * | 160M | EV / Sales 2024 * | 14.9 x |
Net cash position 2024 * | 594M | Net cash position 2025 * | 799M | EV / Sales 2025 * | 8.81 x |
P/E ratio 2024 * |
70.8
x | P/E ratio 2025 * |
29.1
x | Employees | 229 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.24% |
Latest transcript on Krystal Biotech, Inc.
1 day | -0.83% | ||
1 week | -1.71% | ||
1 month | -0.11% | ||
3 months | -4.63% | ||
6 months | +50.62% | ||
Current year | +29.01% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 16-04-14 | |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 16-10-31 |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Dino Rossi
BRD | Director/Board Member | 69 | 17-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 160 | -0.96% | 187,581 |
24-05-30 | 161.6 | +3.36% | 198,886 |
24-05-29 | 156.4 | -1.67% | 154,069 |
24-05-28 | 159 | -2.35% | 238,150 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.01% | 4.57B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.61% | 21.96B | |
-8.24% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- KRYS Stock